| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.66B | $1.75B | $1.83B |
| YoY Revenue Growth % | -5.0% | -4.5% | — |
| Gross Profit | $987.0M | $1.06B | — |
| Gross Margin % | 59.4% | 60.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $205.0M | $209.0M | $186.0M |
| Operating Margin % | 12.3% | 11.9% | 10.1% |
| Net Income (GAAP) | $130.0M | $114.0M | $62.0M |
| EBITDA (Normalized) | $220.2M | $228.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $305.0M | $303.0M | $375.0M |
| Capital Expenditures (CapEx) | $19.0M | $24.0M | — |
| Free Cash Flow (FCF) | $286.0M | $279.0M | $375.0M |
| FCF Margin % | 17.2% | 15.9% | 20.5% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $493.0M | $420.0M | — |
| Total Debt (Short + Long Term) | $431.0M | $455.0M | — |
| Total Stockholders' Equity | $230.0M | $133.0M | — |